Haemonetics (HAE) P/E ratio

P/E ratio today
53.5×

Haemonetics (HAE) trades at 53.5× its earnings per share over the last twelve months. At the end of fiscal 2026 (March 31, 2026) its P/E ratio was 27.5×. That is 43.2% higher than the 19.2× of fiscal 2025. Figures as of 18 Nov 2026, 10:35 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

P/E ratio today
53.5×
P/E ratio, fiscal 2026
27.5×
Change on fiscal 2025
+43.2%
Highest on record
140.4×fiscal 2015
Lowest on record
19.2×fiscal 2025
Fiscal years on record
162009–2026

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Figures, not advice.

Haemonetics P/E ratio, in more detail

Today's figure is 94.6% above the fiscal 2026 year-end.

Across the 16 fiscal year-ends on record (2009–2026), the highest was 140.4× in fiscal 2015 and the lowest 19.2× in fiscal 2025. Today's P/E ratio is higher than at 63% of the 16 fiscal year-ends on record; their median is 40.3×.

History · 16 fiscal years

P/E ratio at each fiscal year-end

The last point is today's figure; the others are fiscal year-ends.

Haemonetics P/E ratio, year by year

Haemonetics (HAE) P/E ratio by fiscal year
Fiscal yearP/E ratioChangeYear endedShare price at year-endDiluted EPS
Today53.5×—$120.92—
202627.5× 43.2% up$56.36$2.05
202519.2× 48.5% down$63.55$3.31
202437.3× 0.9% up$85.35$2.29
202336.9× 38.8% down$82.75$2.24
202260.3× 39.0% up$50.67$0.84
202143.4× 35.6% down$67.26$1.55
202067.3× 19.9% down$99.66$1.48
201984.1× 2.3% down$87.48$1.04
201886.1×—$73.16$0.85
2017——$40.57-$0.51
2016——$32.43-$1.09
2015140.4× 188.6% up$44.92$0.32
201448.6× 13.6% down$32.59$0.67
201356.3× 110.1% up$41.66$0.74
201226.8× 19.1% up$34.84$1.30
201122.5× 12.9% down$35.10$1.56
201025.8× 6.5% up$28.93$1.12
200924.3×—$27.54$1.14

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

The P/E ratio is the share price divided by earnings per share: for past years this page divides the closing price for the month each fiscal year ended in by that year's diluted earnings per share, and a year with a loss has no P/E.

How to read it

It is the number of years of current profit the price pays for — a high figure means investors expect growth, and it is best judged against the company's own history.

P/E ratio at health care companies of similar size

P/E ratio of Haemonetics and comparable companies
CompanyP/E ratio
Haemonetics HAE53.5×
Concentra Group Holdings Parent CON25.1×
Merit Medical Systems MMSI31.6×

Price over the last twelve months' earnings per share, as the market data feed reports it.

More on HAE

Haemonetics, figure by figure

Haemonetics (HAE) overview: price, valuation and scorecardAll health care companies by market value

Haemonetics P/E ratio: questions and answers

What is Haemonetics's P/E ratio?

Haemonetics (HAE) trades at 53.5× its earnings per share over the last twelve months. At the end of fiscal 2026 (March 31, 2026) its P/E ratio was 27.5×. That is 43.2% higher than the 19.2× of fiscal 2025.

Is Haemonetics's P/E ratio high or low compared with its own history?

Today's P/E ratio is higher than at 63% of the 16 fiscal year-ends on record; their median is 40.3×.

What are the highest and lowest P/E ratio figures on record for Haemonetics?

Across the 16 fiscal year-ends on record (2009–2026), the highest was 140.4× in fiscal 2015 and the lowest 19.2× in fiscal 2025.

How is Haemonetics's P/E ratio calculated?

The P/E ratio is the share price divided by earnings per share: for past years this page divides the closing price for the month each fiscal year ended in by that year's diluted earnings per share, and a year with a loss has no P/E. For Haemonetics it is on record here for 16 fiscal years, 2009 to 2026.

Share prices are Yahoo Finance's monthly closes: a fiscal year-end is paired with the close of the month it falls in, and today's quote may be delayed. Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Haemonetics (HAE) P/E ratio”, data as of 18 November 2026. https://funkfolio.com/stock/HAE/pe-ratio

Underlying data: the company's filings with the SEC and Yahoo Finance.